Article Details
Retrieved on: 2021-04-12 10:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Regeneron scientists designed casirivimab and imdevimab, a cocktail of two monoclonal antibodies, to block infectivity of SARS-CoV-2 virus.
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here